SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-13-174179
Filing Date
2013-04-25
Accepted
2013-04-25 17:17:00
Documents
7
Period of Report
2013-06-12
Effectiveness Date
2013-04-25

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT d500782ddef14a.htm DEF 14A 850410
2 GRAPHIC g500782g46y86.jpg GRAPHIC 7878
3 GRAPHIC g500782pc_pg001a.jpg GRAPHIC 42535
4 GRAPHIC g500782pc_pg001b.jpg GRAPHIC 40752
5 GRAPHIC g500782pc_pg001c.jpg GRAPHIC 3830
6 GRAPHIC g500782pc_pg001d.jpg GRAPHIC 14937
7 GRAPHIC g500782pc_pg001e.jpg GRAPHIC 42420
  Complete submission text file 0001193125-13-174179.txt   1062333
Mailing Address 501 CANAL BLVD POINT RICHMOND TECH CNTR. RICHMOND CA 94804
Business Address 501 CANAL BLVD POINT RICHMOND TECH CNTR. RICHMOND CA 94804 5109706000
SANGAMO BIOSCIENCES INC (Filer) CIK: 0001001233 (see all company filings)

IRS No.: 680359556 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-30171 | Film No.: 13783894
SIC: 2836 Biological Products, (No Diagnostic Substances)